Vimarsana
Biggest News Aggregation in the World

Acthar Gel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acthar Gel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acthar Gel Today - Breaking & Trending Today

Mallinckrodt Announces Journal Publication of Real-World Data on Acthar® Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non-African American Patients - Vimarsana News

Mallinckrodt Announces Journal Publication of Real-World Data on Acthar® Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non-African American Patients

/PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced the publication of findings from a retrospective chart review of...

Global Corneal Ulcer Treatment Industry to Surge at a 5.7% CAGR, Surpassing US$ 1.27 Billion in Mark - Vimarsana News

Global Corneal Ulcer Treatment Industry to Surge at a 5.7% CAGR, Surpassing US$ 1.27 Billion in Mark

The Global Corneal Ulcer Treatment Industry is on the brink of substantial expansion, with a projected market valuation of US$ 1.27 billion by 2029, according to the latest analysis by Future Market Insights (FMI). As of 2022, the market stands at approximately US$ 867.3 million, and a noteworthy 5.7% Compound Annua...

Mallinckrodt Avoids $40 Million SEC Fine in Medicaid Overcharge Case - Vimarsana News

Mallinckrodt Avoids $40 Million SEC Fine in Medicaid Overcharge Case

The pharmaceutical company agreed to hire a compliance consultant to conduct a comprehensive review of its disclosure and internal accounting controls

Source: wsj.com
Processa Pharmaceuticals (NASDAQ: PCSA): Revolutionizing Cancer Treatment through Next-Generation Chemotherapies - Vimarsana News

Processa Pharmaceuticals (NASDAQ: PCSA): Revolutionizing Cancer Treatment through Next-Generation Chemotherapies

Processa Pharmaceuticals’ (NASDAQ: PCSA) shares skyrocketed by over 260% from their October lows of $0.18 per share. Shares peaked at $0.65 on November 14th and more recently has consolidated around $0.43. The reason for this surge was not immediately clear given the lack of material  events. However upon digging deeper, we’ve uncovered a very interesting […]

Mallinckrodt Completes Financial Restructuring and Irish Examinership Proceedings and Emerges From Chapter 11 - Vimarsana News

Mallinckrodt Completes Financial Restructuring and Irish Examinership Proceedings and Emerges From Chapter 11

/PRNewswire/ -- Mallinckrodt plc ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has completed its...